Journal Article Research Support, Non-U.S. Gov't Review Ppublish 97 citations
PubMed: 32857853 DOI: 10.1093/nar/gkaa713
Recent advances in the nucleolar responses to DNA double-strand breaks.
Nucleic Acids Res 48(17):9449-9461
Authors: Lea Milling Korsholm, Zita Gál, Blanca Nieto, Oliver Quevedo, Stavroula Boukoura, Casper Carstens Lund, Dorthe Helena Larsen
Affiliations
- Danish Cancer Society Research Center, Nucleolar Stress and Disease Group, Strandboulevarden 49, 2100 Copenhagen, Denmark.
Abstract
DNA damage poses a serious threat to human health and cells therefore continuously monitor and repair DNA lesions across the genome. Ribosomal DNA is a genomic domain that represents a particular challenge due to repetitive sequences, high transcriptional activity and its localization in the nucleolus, where the accessibility of DNA repair factors is limited. Recent discoveries have significantly extended our understanding of how cells respond to DNA double-strand breaks (DSBs) in the nucleolus, and new kinases and multiple down-stream targets have been identified. Restructuring of the nucleolus can occur as a consequence of DSBs and new data point to an active regulation of this process, challenging previous views. Furthermore, new insights into coordination of cell cycle phases and ribosomal DNA repair argue against existing concepts. In addition, the importance of nucleolar-DNA damage response (n-DDR) mechanisms for maintenance of genome stability and the potential of such factors as anti-cancer targets is becoming apparent. This review will provide a detailed discussion of recent findings and their implications for our understanding of the n-DDR. The n-DDR shares features with the DNA damage response (DDR) elsewhere in the genome but is also emerging as an independent response unique to ribosomal DNA and the nucleolus.
MeSH
Cells, Genome, Nucleic Acids, Dna
Cited by
- Harnessing eukaryotic retroelement proteins for transgene insertion into human safe-harbor loci. Nat Biotechnol, 2025
- An Overview of UBTF Neuroregression Syndrome. Brain Sci, 2024
- RNA Pol I activity maintains chromatin condensation and the H3K4me3 gradient essential for oogenesis, independent of ribosome production. bioRxiv, 2025
- TCOF1 coordinates oncogenic activation and rRNA production and promotes tumorigenesis in HCC. Cancer Sci, 2022
- Effects of Human Nucleolus Upon Guest Viral-Life, Focusing in COVID-19 Infection: A Mini- Review. Iran J Pathol, 2022
- Treacle Sticks the Nucleolar Responses to DNA Damage Together. Front Cell Dev Biol, 2022
- Hyper-recombination in ribosomal DNA is driven by long-range resection-independent RAD51 accumulation. Nat Commun, 2024
- The Role of Gene in Health and Disease: Beyond Treacher Collins Syndrome. Int J Mol Sci, 2021
- The Novel Role of hnRNP UL1 in Human Cell Nucleoli. Int J Biol Sci, 2022
- Nuclear and genome dynamics underlying DNA double-strand break repair. Nat Rev Mol Cell Biol, 2025
- The unique Pt(II)-induced nucleolar stress response and its deviation from DNA damage response pathways. J Biol Chem, 2024
- MUSICiAn: Genome-wide Identification of Genes Involved in DNA Repair via Control-Free Mutational Spectra Analysis. bioRxiv, 2025
- Nucleolus and Nucleolar Stress: From Cell Fate Decision to Disease Development. Cells, 2022
- It Takes a Village of Chromatin Remodelers to Regulate rDNA Expression. Int J Mol Sci, 2025
- NAT10 resolves harmful nucleolar R-loops depending on its helicase domain and acetylation of DDX21. Cell Commun Signal, 2024
- APE1 assembles biomolecular condensates to promote the ATR-Chk1 DNA damage response in nucleolus. Nucleic Acids Res, 2022
- Early nucleolar responses differentiate mechanisms of cell death induced by oxaliplatin and cisplatin. J Biol Chem, 2021
- Integrative phosphoproteomics defines two biologically distinct groups of KMT2A rearranged acute myeloid leukaemia with different drug response phenotypes. Signal Transduct Target Ther, 2023
- HIV Vpr activates a nucleolar-specific ATR pathway to degrade the nucleolar stress sensor CCDC137. Nucleic Acids Res, 2025
- Harnessing the Nucleolar DNA Damage Response in Cancer Therapy. Genes (Basel), 2022